Editorial: Gleason score assignment is the sole responsibility of the pathologist Murali Varma, Dan Berney, Jon Oxley, Kiril Trpkov
Histopathology 2018;73:5-7. https://onlinelibrary.wiley.com/doi/abs/10.1111/his.13472
J Clin Pathol 2018;71:874-878 https://jcp.bmj.com/content/71/10/874.abstract
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Hashim UAhmedFRCSab* AhmedEl-Shater BosailyMBBChab* Louise CBrownPhDd* RhianGabePhDe ProfRichardKaplanFRCPd ProfMahesh KParmarDPhild YolandaCollaco-MoraesPhDd KatieWardBScd Richard GHindleyFRCSf AlexFreemanFRCPathg Alex PKirkhamFRCRh RobertOldroydMAi ChrisParkerFRCRc ProfMarkEmbertonFRCSabPROMIS study group†
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis Veeru Kasivisvanathan, M.R.C.S., Antti S. Rannikko, Ph.D., Marcelo Borghi, M.D., Valeria Panebianco, M.D., Lance A. Mynderse, M.D., Markku H. Vaarala, Ph.D., Alberto Briganti, Ph.D., Lars Budäus, M.D., Giles Hellawell, F.R.C.S.(Urol.), Richard G. Hindley, et al., for the PRECISION Study Group Collaborators*
A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial James S.Wysocka Andrew B.Rosenkrantzb William C.Huanga Michael D.Stifelmana HerbertLepora Fang-MingDengc JonathanMelamedc Samir S.Tanejaa
Eur Urol. 2018 Jul;74(1):48-54. doi: 10.1016/j.eururo.2018.03.007. Epub 2018 Mar 19.
Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What’s Next? Panebianco V1, Barchetti G2, Simone G3, Del Monte M4, Ciardi A4, Grompone MD4, Campa R4, Indino EL4, Barchetti F4, Sciarra A5, Leonardo C5, Gallucci M3, Catalano C6.
Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool Gabriele Gaziev, Karan Wadhwa, Tristan Barrett, Brendan C. Koo, Ferdia A. Gallagher, Eva Serrao, Julia Frey, Jonas Seidenader, Lina Carmona, Anne Warren.
Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi, Tomoaki Miyagawa
Nuclear Magnetic Resonance Imaging of the Prostate H. Steyn, W. Smith First published: December 1982 British Journal of Urology – Volume 54, Issue 6
NMR scanning of the pelvis: initial experience with a 0.3 T system PJ Bryan, HE Butler, JP LiPuma, Haaga, JR … Show all
MR imaging of the prostate gland: normal anatomy H Hricak, GC Dooms, JE McNeal, AS Mark.
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting LouiseDickinsonabc Hashim U.Ahmedab ClareAllend Jelle O.Barentsze BrendanCareyf Jurgen J.Futterere Stijn W.Heijminke Peter J.Hosking AlexKirkhamd Anwar R.Padhanih RajPersadi PhilippePuechj ShonitPunwanid Aslam S.Sohaibk BertrandTomball ArnauldVillersm Janvan der Meulencn MarkEmbertonabc
DWI of Prostate Cancer: Optimal -Value in Clinical Practice Guglielmo Manenti,1 Marco Nezzo,1 Fabrizio Chegai,1 Erald Vasili,1Elena Bonanno,2 and Giovanni Simonetti1
The impact of computed high b-value images on the diagnostic accuracy of DWI for prostate cancer: A receiver operating characteristics analysis Peigang Ning, Dapeng Shi, Geoffrey A. Sonn, Shreyas S. Vasanawala, Andreas M. Loening, Pejman Ghanouni, Piotr Obara, Lewis K. Shin, Richard E. Fan, Brian A. Hargreaves & Bruce L. Daniel Journal of Magnetic Resonance Imaging Volume 36, Issue 1
Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) Kazuhiro Kitajima MD, PhD, Satoru Takahashi MD, PhD, Yoshiko Ueno MD, Takeshi Yoshikawa MD, PhD, Yoshiharu Ohno MD, PhD, Makoto Obara PhD… See all authors
National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meeting Mrishta Brizmohun Appayya, 1 Jim Adshead, 2 Hashim U. Ahmed, 3 , 4Clare Allen, 5 Alan Bainbridge, 6 Tristan Barrett, 7 Francesco Giganti, 3 , 5John Graham, 8 Phil Haslam, 9 Edward W. Johnston, 1 , 5Christof Kastner, 10 Alexander P.S. Kirkham, 5 Alexandra Lipton, 11Alan McNeill, 12 Larissa Moniz, 13 Caroline M. Moore, 4 , 14 Ghulam Nabi, 15 Anwar R. Padhani, 16 Chris Parker, 17 Amit Patel, 18Jacqueline Pursey, 19 Jonathan Richenberg, 20 John Staffurth, 21Jan van der Meulen, 22 Darren Walls, 23 and Shonit Punwani 1 , 5
Eur Radiol. 2012 Apr;22(4):746-57. doi: 10.1007/s00330-011-2377-y. Epub 2012 Feb 10.
ESUR prostate MR guidelines 2012 Barentsz JO1, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ; European Society of Urogenital Radiology.
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2Jeffrey C.Weinreba† Jelle O.Barentszb† Peter L.Choykec FrancoisCornudd Masoom A.Haidere Katarzyna J.Macuraf DanielMargolisg Mitchell D.Schnallh FainaShterni Clare M.Tempanyj Harriet C.Thoenyk SadnaVermal
Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use Jelle O. Barentsz. Correspondence information about the author Jelle O. Barentsz, Jeffrey C. Weinreb, Sadhna Verma, Harriet C. Thoeny, Clare M. Tempany, Faina Shtern, Anwar R. Padhani, Daniel Margolis, Katarzyna J. Macura, Masoom A. Haider, Francois Cornud, Peter L. Choyke Journal of Magnetic Resonance Imaging Volume 48, Issue 2
All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map Matthew D. Greer MD, Joanna H. Shih PhD, Tristan Barrett MD, Sandra Bednarova MD, Ismail Kabakus MD, Yan Mee Law MD, Haytham Shebel MD, Maria J. Merino MD… See all authors First published: 17 January 2018
Prostate MRI: Who, when, and how? Report from a UK consensus meeting A.P.S.Kirkhama P.Haslamb J.Y.Keaniec I.McCaffertyd A.R.Padhanie S.Punwania J.Richenbergf G.Rottenbergg A.Sohaibh P.Thompsonf L.W.Turnbulli L.Kurbanj A.Sahdevk R.Clementsl B.M.Careym C.Allena
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force Caroline M.Mooreab‡ FrancescoGiganticd‡ PeterAlbertsene ClareAllenc ChrisBangmaf AlbertoBrigantig PeterCarrollh MasoomHaider iVeeruKasivisvanathanab AlexKirkhamc LaurenceKlotzj AdilOuzzanek Anwar R.Padhanil ValeriaPanebiancom PeterPinton PhilippePuecho AnttiRannikkop RaphaeleRenard-Pennaq IvoSchootsx
Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program FrancescoGigantiab ClareAllena Jonathan W.Piperc DavidMirandoc ArmandoStabilebd eShonitPunwaniaf AlexKirkhama MarkEmbertonbe Caroline M.Moorebe
European Urology Volume 66, Issue 2, August 2014, Pages 343-351 James S.Wysocka Andrew B.Rosenkrantzb William C.Huanga Michael D.Stifelmana HerbertLepora Fang-MingDengc JonathanMelamedc Samir S.Tanejaa BJU International Volume 117, Issue 1
Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool Gabriele Gaziev, Karan Wadhwa, Tristan Barrett, Brendan C. Koo, Ferdia A. Gallagher, Eva Serrao, Julia Frey, Jonas Seidenader, Lina Carmona, Anne Warren… See all authors First published: 07 August 2014 BJU International Volume 119, Issue 2
Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patientsSatoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi, Tomoaki Miyagawa First published: 02 March 2016
VANGUARDS: ‘Each vanguard will take a lead on the development of new care models which will act as the blueprints for the NHS moving forward and the inspiration to the rest of the health and care system’(www.england.nhs.uk/ourwork/futurenhs/new-care-models)